Xufang DAI, Liyan QIN, Jiqin LIAN. Resveratrol improves autistic behaviors in rat model[J]. Journal of Third Military Medical University, 2017, 39(13): 1360-1365.
DOI:
Xufang DAI, Liyan QIN, Jiqin LIAN. Resveratrol improves autistic behaviors in rat model[J]. Journal of Third Military Medical University, 2017, 39(13): 1360-1365. DOI: 10.16016/j.1000-5404.201703153.
Resveratrol improves autistic behaviors in rat model
To determine the effect of resveratrol on the behaviors of autistic rats and investigate the possible mechanism.
Methods
2
Rat model of autism was inflicted by intraperitoneal injection of sodium valproate (VPA) in rats after pregnancy for 12.5 d. The pregnant rats of the resveratrol group were treated with resveratrol
via
subcutaneous injection at a dose of 3.6 mg/kg per day from E6 to E18. Then the offspring were randomly divided to 4 groups: control
VPA treatment
resveratrol treatment
and VPA+resveratrol treatment groups (
n
=3 for each group). The repetitive behavior
neural behavior and social interaction were evaluated in the young rats in 35 d after born. The expression levels of LC3-Ⅱ and SIRT1 in brain tissues were detected by Western blotting.
Results
2
The rat model of autism was established successfully. Compared to the control rats
the rats treated with VPA showed excessive repetitive behavior
lower social interaction
longer moving time and distance in central area
and reduced standing times (
P
<
0.05)
which were in accordance with the typical behaviors of autistic rats. Treatment with resveratrol alone resulted in no obvious changes in the social interaction and neural behavior in the young rats
but resveratrol treatment corrected the VPA-induced autistic-like behaviors (
P
<
0.05). Western blotting indicated that VPA treatment reduced the levels of SIRT1and LC3-Ⅱin the brain tissues including prefrontal lobe
seahorse and cerebellum. However
resveratrol attenuated VPA-triggered down-regulation of SIRT1 and LC3-Ⅱ.
Conclusion
2
Resveratrol may correct the behaviors of autistic rats through SIRT1 enhancement mediated autophagy up-regulation.
关键词
Keywords
references
NAPOLI E, DUENAS N, GIULIVI C. Potential therapeutic use of the ketogenic diet in autism spectrum disorders[J]. Front Pediatr, 2014, 2: 69. DOI: 10.3389/fped.2014.00069.
CHEN W X. Seventy years autism:From kanner to dsm-v[J]. Journal of Clinical Pediatrics, 2013, 31(11): 1001-1004. 1111111155555555
MATSON J L, JANG J. Treating aggression in persons with autism spectrum disorders: a review[J]. Res Dev Disabil, 2014, 35(12): 3386-3391. DOI:10.1016/j.ridd.2014.08.025.
TANG G, GUDSNUK K, KUO S H, , et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits[J]. Neuron, 2014, 83(5): 1131-1143. DOI:10.1016/j.neuron.2014.07.040.
SAHIN M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream[J]. Curr Opin Neurobiol, 2012, 22(5): 895-901. DOI:10.1016/j.conb.2012.04.008.
ZHANG Y, CHEN M L, GAO Y X, et al.Resveratrol attenuates steatosis in cultured hepatic cells by inducing autophagy[J].J Third Mil Med Univ, 2014, 36(21):2178-2182.
DENG H Y, MI M T.Resveratrol attenuates Aβ25-35 induced neurotoxicity via activation of SIRT1/autophagy signaling pathway[J].J Third Mil Med Univ, 2016, 38(06):619-622. 1111111155555555
CAPUTO M, MATARESE G, PIERANTONI G M, et al. Convergent effects of resveratrol and PYK2 on prostate cells[J]. Int J Mol Sci, 2016, 17(9): E1542. DOI: 10.3390/ijms17091542.
SCHNEIDER T, PRZEWŁOCKI R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism[J]. Neuropsychopharmacology, 2005, 30(1): 80-89. DOI:10.1038/sj.npp.1300518.
BORRIELLO A, BENCIVENGA D, CALDARELLI I, et al. Resveratrol: from basic studies to bedside[J]. Cancer Treat Res, 2014, 159: 167-184. DOI:10.1007/978-3-642-38007-5_10.
CHEN W, SUN Y, LIU K, et al. Autophagy: a double-edged sword for neuronal survival after cerebral ischemia[J]. Neural Regen Res, 2014, 9(12): 1210-1216. DOI:10.4103/1673-5374.135329.
DERE E, DAHM L, LU D, et al. Heterozygous ambra1 deficiency in mice: a genetic trait with autism-like behavior restricted to the female gender[J]. Front Behav Neurosci. 2014, 16(8):181. DOI: 10.3389/fnbeh.2014.00181.
POULTNEY C S, GOLDBERG A P, DRAPEAU E, et al. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder[J]. Am J Hum Genet, 2013, 93(4): 607-619. DOI:10.1016/j.ajhg.2013.09.001.
WANG R, LIU Y Y, LIU X Y, et al. Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model[J]. Cell Physiol Biochem, 2014, 34(3): 854-864. DOI:10.1159/000366304.
LIU S, LI T, LIU H, et al. Resveratrol exerts antidepressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex[J]. Behav Brain Res, 2016, 302: 191-199. DOI:10.1016/j.bbr.2016.01.037.
LIN C J, CHEN T H, YANG L Y, et al. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death[J]. Cell Death Dis, 2014, 5: e1147. DOI:10.1038/cddis.2014.123.
WANG F, CUI N, YANG L, et al. Resveratrol rescues the impairments of hippocampal neurons stimulated by microglial over-activation in vitro [J ] . Cell Mol Neurobiol, 2015, 35(7): 1003-1015. DOI:10.1007/s10571-015-0195-5.
APPUHAMY J A, NAYANANJALIE W A, ENGLAND E M, et al. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells[J]. J Dairy Sci, 2014, 97(1): 419-429. DOI:10.3168/jds.2013-7189.
NG F, TANG B L. Sirtuins'modulation of autophagy[J]. J Cell Physiol, 2013, 228(12): 2262-2270. DOI:10.1002/jcp.24399.
ZHANG Y H, YANG C L, CUI W G, et al. Effects of sulindac on oxidative stress in an autistic model induced by pre-natal exposure to valproic acid[J]. Chinese Journal of Pathophysiology, 2014, 30(12): 2161-2165. DOI:10.3969/j.issn.1000-4718.2014.12.008.